pulmicort turbohaler preisvergleich zenegra 100 dosage natural alternative to differin natural alternative claritin d wo kann ich clomid kaufen himalaya septilin syrup 200ml silagra 50 mg cipla sildenafil preis kaufen prednisone alternative what is voveran 50 ge fertomid 100mg side effects hydrochlorothiazide 50 mg dosage levaquin 500 mg price generika viagra soft parlodel 10 mg alternative to risperdal autism alli tabletten preis aciclovir 750 mg iv generika für cymbalta l-tryptophan 220mg generika keppra levothroid 100 mcg prazosin alternatives amoxicillin 500mg lamisil tabletten ohne rezept kaufen aspirin kaufen schweiz tadalis 100mg alternative à l'atarax levaquin 750 mg generic serevent dosieraerosol preis viramune kaufen feldene d 20mg advair 150 coupon keppra 750 mg cost digoxin 50 mcg fluoxetine online kaufen zithromax preis österreich lithium 500mg generika viramune lioresal preis schweiz augmentin 250 mg tablets brand cialis 20mg singulair ersatz trileptal 1500 mg unique hoodia preis zithromax 250 preis diamox alternative is there a natural alternative to prilosec caverta 50 mg side effects seroquel alternative drugs zantac 50 l tryptophan kaufen priligy dapoxetine kaufen seroflo 200 tadalafil 10 levaquin 500mg used nitrofurantoin retard preis allopurinol alternative medicine kamagra gel für frauen alternative zu blopress best alternative bystolic motilium tabletten ohne rezept ersatz für voltaren salbe natural alternative zyban ticket kaufen allianz arena alphagan preis thuoc ofloxacin 200mg compazine 10 mg oral tablet asacol 500mg suppositories uroxatral 10 mg levaquin alternative antibiotic claritin preis atarax ohne rezept kaufen motilium tabletten ohne rezept premarin 250 cheap alternative to levitra brahmi wo kaufen tamoxifen natural alternatives gasex tablets 100 alternatives to lamictal for depression serevent dosieraerosol preis duphalac alternative glucotrol 20 mg serevent diskus 60 einzeln p preisvergleich phexin 500 mg used for zyloprim 200 mg levlen ed tablet 150mcg 30mcg fosamax 10 alternative zu bupropion ponstel 250 dosage glucophage sr 1000 mg hydrea 500 mg caps 100 Creepy vs. Donor-Centered - Collins Group
Skagit Valley Hospital

Creepy vs. Donor-Centered



About a week ago, the Wall Street Journal published an article entitled “Smart Money: Is Your Favorite Charity Spying on You?

The article describes how nonprofits research donors by using wealth screening tools, public records and databases that provide career and education information, stock holdings, charitable giving history, campaign contributions, and home and real estate values. Researchers have been mining this data for years; it’s nothing new. What’s new is how the internet and software tools have made the practice quicker, easier, and more comprehensive.

To those of us in the profession, we understand that this (publically available and legally-obtained) information is just one part of the equation that will help us understand our organization’s best donors and prospects. This information is balanced with a donor’s affinity for our organization and work, their giving history to us, and their connections to our staff and volunteer leaders. Together, this helps development staff focus their efforts, and make the best use of time and money, in order to advance their missions and create positive change for their communities.

Last week I attended the Willamette Valley Development Officers regional conference and heard Portland State University staff describe a program to connect with donors and alumni. Initial phone calls placed by a recent alum help PSU learn about their donors’ interests and experiences and their communication preferences so that staff can best engage with them in the areas they care about. This program is successful in identifying donors who are interested in learning more about PSU, its schools, and future plans, and those who are not – all of which is important information for their development staff. Their program is respectful, responsive, donor-centered – and research-based.

How do we avoid being creepy? By following the ethical standards set by the Association for Fundraising Professionals and the Association of Prospect Researchers for Advancement, and by developing donor confidentiality and prospect research policies for our organizations to ensure that information is used judiciously and respectfully. Also, by not saying creepy things to donors (or anyone for that matter) such as “when I was googling you the other day, I saw that…”

As far as the special treatment we bestow upon those we see as future major donors, a question brought up in the WSJ article in reference to hospitals and medical institutions, that is one each organization must reconcile for itself. Are you donor-centered or creepy? What would your donors say?


Like this post? Why not share it?


About the Author

Natalie Lamberjack

Natalie Lamberjack CFRE

Senior Consultant

Natalie dials into the needs of her clients by keeping a calm eye on the big picture view of the nonprofit sector.


Leave a Reply